Every Form 4 that Omada Health, Inc. (OMDA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow OMDA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OMDA filings page.
Klapstein Julie D reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Julie D. Klapstein received a grant of 10,882 restricted stock units, each representing one share of Common Stock at no purchase price. Following this award, she holds 21,316 shares directly. The RSUs vest 100% on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders, subject to continued service.
Omada Health, Inc. director Anne Beal received a grant of 10,882 shares of Common Stock in the form of restricted stock units (RSUs). The RSUs have no cash exercise price and will convert into one share of Common Stock per unit when they vest.
According to the award terms, 100% of the RSUs will vest on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of stockholders, if she continues in service through that date. After this grant, Beal directly holds 20,618 shares of Omada Health common stock.
Jain Sachin H. reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Sachin H. Jain received a grant of 10,882 restricted stock units, each convertible into one share of Common Stock upon vesting. After this award, he holds 20,618 shares of Common Stock directly. The RSUs vest 100% on the earlier of the first anniversary of the grant date or the date of Omada Health’s 2027 Annual Meeting of stockholders, contingent on his continued service through that vesting date.
Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported an open-market sale of 14,960 shares of common stock on June 16, 2026 at an average price of $17.3604 per share. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026, indicating it was pre-scheduled.
Following the sale, Duffy directly holds 411,861 shares of Omada Health common stock. In addition, 851,659 shares are held indirectly in family trusts for the benefit of his family members, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Omada Health, Inc. Chief Financial Officer Steven L. Cook sold 6,800 shares of common stock in an open-market transaction. The sale took place on June 15, 2026 at a weighted average price of $17.2329 per share, based on multiple trades between $17.00 and $17.47.
The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan that Cook adopted on March 14, 2026, indicating it was scheduled in advance rather than timed discretionarily. Following this sale, he directly holds 187,209 shares of Omada Health common stock.
Omada Health, Inc. Chief Accounting Officer Gracey Craig sold 6,894 shares of Common Stock on June 12, 2026 in an open-market transaction at a weighted average price of $17.4243 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026. Following this transaction, Craig directly owns 9,191 Omada Health shares.
Omada Health, Inc. President Shao Wei-Li reported an open-market sale of 4,589 shares of common stock at a weighted average price of $17.2407 per share. After this transaction, Wei-Li directly holds 316,238 shares. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026.
Omada Health, Inc.'s Chief Executive Officer Sean P. Duffy reported routine share dispositions in company stock. He made a bona fide gift of 9,450 shares of common stock and had 4,422 shares withheld to cover tax obligations. After these transactions, he holds 426,821 shares directly and 851,659 shares indirectly through family trusts, where he disclaims beneficial ownership except for his pecuniary interest.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an automatic share disposition related to taxes. On the reported date, 2,010 shares of Common Stock were withheld at a price of $17.93 per share to satisfy tax obligations. After this tax-withholding disposition, he held 194,009 shares of Common Stock directly.
Omada Health, Inc. President Shao Wei-Li reported a tax-related share disposition. On the transaction date, 1,843 shares of Common Stock were withheld at a price of $17.93 per share to cover tax obligations. After this non-market transaction, Shao Wei-Li directly held 320,827 shares.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported a tax-related share disposition. On June 1, 2026, 4,493 shares of Common Stock were withheld at $18.38 per share to satisfy tax obligations, classified as a tax-withholding disposition rather than an open-market sale.
After this transaction, Cook directly holds 196,019 shares of Omada Health common stock. The filing shows no option exercises or open-market purchases or sales, indicating this was a routine compensation-related tax event.
Omada Health, Inc. Chief Accounting Officer Craig Gracey reported a small tax-related share transaction. On June 1, 2026, 385 shares of Common Stock were disposed of as a tax-withholding disposition, using shares valued at $18.38 each to cover tax obligations. After this non-market event, Gracey directly holds 16,085 Common Stock shares.
Omada Health, Inc. President Shao Wei-Li reported a tax-related share disposition. On June 1, 2026, 6,180 shares of common stock were withheld at $18.38 per share to cover tax obligations. After this non-market transaction, Shao Wei-Li directly holds 322,670 shares of Omada Health common stock.
Omada Health, Inc. CEO Sean P. Duffy reported a routine tax-related share withholding and updated his holdings. A total of 9,884 shares of common stock were disposed of at $18.38 per share as a tax-withholding disposition, leaving him with 440,693 shares held directly. He also has 851,659 shares reported as held indirectly through family trusts for the benefit of family members, for which he disclaims beneficial ownership except for his pecuniary interest.
Omada Health, Inc. President Wei-Li Shao sold shares in a planned open-market transaction. On April 8, 2026, Shao sold 2,829 shares of Omada Health Common Stock at a weighted average price of $12.7062 per share in an open-market sale. After this transaction, Shao directly owns 328,850 shares. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on August 15, 2025, indicating the trade was pre-arranged rather than a discretionary market-timed decision.
Omada Health, Inc. director Jeryl L. Hilleman received an equity grant in the form of restricted stock units. The filing reports an acquisition of 1,544 shares of Common Stock at a stated price of $0.00 per share, classified as a grant or award rather than a market purchase.
The RSUs were granted under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents the right to receive one share of Common Stock upon settlement. After this award, Hilleman directly holds 14,338 shares of Omada Health common stock.
ROOT JONATHAN D reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Jonathan D. Root received an equity award of 882 shares of Common Stock in the form of restricted stock units granted under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents one share of Common Stock, to be settled on a date chosen by the director under the program or as otherwise specified by the program. Following this grant, he directly holds 180,175 shares of Common Stock. This is a compensation-related award, not an open-market purchase.
Klapstein Julie D reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Julie D. Klapstein received an award of 698 shares of Common Stock in the form of restricted stock units (RSUs). The RSUs were granted under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees and carry a grant price of $0.00 per share.
Each RSU represents the right to receive one share of Common Stock, with settlement to occur on a date selected by the director or as otherwise provided by the program. Following this compensatory grant, Klapstein’s direct holdings total 10,434 shares of Common Stock reported in this filing.
FETTER TREVOR reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Trevor Fetter received a grant of 955 restricted stock units (RSUs) of Common Stock. The award was issued under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees and carries a grant price of $0.00 per share.
Each RSU represents one share of Common Stock to be settled on a date selected by the director or as otherwise provided by the program. Following this grant, he holds 12,651 shares directly. The filing also records a transfer of 111,200 shares from a limited liability company to a family trust where he is a trustee and beneficiary, bringing his indirect holdings to 111,200 shares.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an open-market sale of 1,884 shares of common stock at $13.94 per share on March 13, 2026. The transaction was made under a Rule 10b5-1 trading plan adopted on August 15, 2025.
After this sale, Cook directly holds 200,512 shares of Omada Health common stock. The sale represents a relatively small portion of his reported holdings and reflects a pre-planned trading arrangement rather than a discretionary trade.
Gracey Craig reported acquisition or exercise transactions in this Form 4 filing.
Omada Health Chief Accounting Officer Craig Gracey received a grant of 16,470 shares of Common Stock in the form of restricted stock units (RSUs). The award vests in 16 equal quarterly installments starting on March 1, 2026, with all RSUs fully vested on the fourth anniversary of that date.
Cook Steven L. reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. reported that its Chief Financial Officer, Steven L. Cook, received a grant of 147,058 shares of Common Stock in the form of restricted stock units. After this award, he holds 202,396 shares directly. The RSUs vest in equal quarterly installments over four years starting from March 1, 2026.
Shao Wei-Li reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. reported that President Wei-Li Shao received a grant of 264,705 restricted stock units (RSUs) of Common Stock at no purchase price. Each RSU represents the right to receive one share upon vesting. The award begins vesting on March 1, 2026, with 1/16 of the RSUs vesting on each quarterly anniversary, reaching full vesting on the fourth anniversary of that date. Following this grant, Shao directly holds 331,679 shares of Omada Health Common Stock.
Omada Health, Inc. reported that Chief Executive Officer Sean P. Duffy received a grant of 323,529 restricted stock units (RSUs) of Common Stock at no cash cost. Each RSU converts into one share upon vesting. One-sixteenth of the RSUs vest on each quarterly anniversary beginning March 1, 2026, so the award fully vests on the fourth anniversary of that date.
After this grant, Duffy beneficially owns 441,127 shares directly. An additional 861,109 shares are held indirectly in family trusts for the benefit of his family members, and he disclaims beneficial ownership of those shares except to the extent of his pecuniary interest.
Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported open-market sales of a total of 4,063 shares of common stock on March 9, 2026. The transactions consisted of 3,863 shares sold at a weighted average price of $14.3151 per share and 200 shares sold at a weighted average price of $14.8850 per share.
According to the filing, these sales were made pursuant to a Rule 10b5-1 trading plan adopted on August 15, 2025, indicating they were pre-scheduled. After these sales, Duffy held 117,598 shares directly. He also had 861,109 shares held indirectly in family trusts for the benefit of his family members, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Omada Health, Inc. President Shao Wei-Li reported a tax-related share disposition under an insider Form 4. On March 5, 2026, 2,105 shares of common stock were disposed of at $13.60 per share to cover tax withholding obligations, a non-open-market transaction. After this tax-withholding disposition, Shao Wei-Li directly owned 66,974 shares of Omada Health common stock.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported a tax-withholding disposition of 2,228 shares of common stock at $13.60 per share on March 5, 2026. After this non-open-market transaction to cover tax obligations, he directly owns 55,338 shares of Omada Health common stock.
Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported a tax-related share disposition. On March 5, 2026, he disposed of 4,983 shares of common stock at $13.60 per share in a transaction coded as a tax-withholding disposition, leaving 121,661 shares held directly.
He also reports 861,109 shares of common stock held indirectly through family trusts noted in a footnote. These trusts hold shares for the benefit of his family members, and he disclaims beneficial ownership of those shares except to the extent of his pecuniary interest.
Omada Health, Inc. chief executive Sean P. Duffy, who also serves as a director, reported several stock option exercises and related share sales. On January 12, 2026, he exercised 230,479 stock options at an exercise price of $2.55 per share and sold 139,989 common shares at a weighted average price of $15.3471 and 90,490 shares at a weighted average price of $15.9877. On January 13, 2026, he exercised an additional 40,796 options at $2.55 and sold 40,796 shares at a weighted average price of $15.9519. The options exercised were non-qualified stock options scheduled to expire on January 27, 2026 and are fully vested. Following these transactions, Duffy directly owns 126,644 common shares and has an additional 861,109 shares reported as indirectly owned through family trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Omada Health, Inc. director Jonathan D. Root received 915 restricted stock units (RSUs) of Common Stock on January 5, 2026. The award was granted at a price of $0 per share under Omada Health’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents the right to receive one share of Common Stock, with settlement to occur on a date Mr. Root selects under the program or as otherwise provided by the program. Following this grant, he beneficially owns 179,293 shares of Common Stock directly.
Omada Health director Trevor Fetter reported an equity award on Form 4. On January 5, 2026, he received 991 restricted stock units (RSUs) of Omada Health, Inc. common stock at a price of $0 per share under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents one share of common stock, with settlement to occur on a date he selects under the program or as otherwise provided by the program.
After this grant, Fetter beneficially owns 11,696 shares directly and 111,200 shares indirectly through a limited liability company of which he is the sole member.
Omada Health, Inc. director Jeryl L. Hilleman received an equity grant of 1,601 shares of Common Stock on 01/05/2026, reported as an acquisition at a price of $0 per share. The filing explains this represents restricted stock units (RSUs) granted under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees, with each RSU convertible into one share of common stock at settlement. Following this grant, Hilleman beneficially owns 12,794 shares of Omada Health common stock in direct ownership.
Omada Health, Inc. director Jeryl L. Hilleman reported an updated equity holding following a restricted stock unit grant and a correction to a prior filing. On 10/05/2025, Hilleman was granted 1,081 restricted stock units (RSUs) of Omada Health common stock under the company’s Non-Employee Director Compensation Program, in lieu of cash retainer fees, at a reported price of $0 per share. Each RSU represents the right to receive one share of common stock, with settlement timing determined under the program or as selected by the director. After this transaction, Hilleman beneficially owned 11,193 shares of common stock. The amendment notes that the original report overstated both the amount of securities acquired and beneficially owned by 45 shares, and this filing corrects those errors.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported a sale of 4,211 shares of the company’s common stock on 12/10/2025 at a weighted average price of $15.3657 per share. The sale was coded as an open market or private sale transaction and was made pursuant to a Rule 10b5-1 trading plan adopted by Cook on 08/15/2025.
The transaction was executed in multiple trades at prices ranging from $15.24 to $15.55 per share. Following this sale, Cook beneficially owns 57,566 shares of Omada Health common stock in direct ownership.
Omada Health, Inc. reported an insider stock sale by Chief Executive Officer and director Sean P. Duffy. On December 10, 2025, he sold 9,266 shares of common stock at a weighted average price of $15.3657 per share in an open-market transaction coded S.
The sale was made under a Rule 10b5-1 trading plan adopted on August 15, 2025. After this transaction, Duffy beneficially owned 126,644 shares directly and 861,109 shares indirectly through family trusts for the benefit of his family members, and he disclaims beneficial ownership of the trust-held shares except to the extent of his pecuniary interest.
Jonathan D. Root, a director of Omada Health, Inc. (OMDA), reported the receipt of 657 restricted stock units (RSUs) on 10/05/2025 issued under the company's Non-Employee Director Compensation Program in lieu of retainer fees. Following this grant, Mr. Root directly beneficially owns 10,630 shares and indirectly beneficially owns 4,717, (4,571,769 + 146,257) shares through affiliated USVP X funds, where he is a managing member of the general partner and disclaims direct beneficial ownership except for any pecuniary interest. The Form 4 was signed by an attorney-in-fact on 10/07/2025.
Insider transaction summary: A Form 4 shows that Trevor Fetter, a director of Omada Health, Inc. (OMDA), was granted 712 restricted stock units (RSUs) on 10/05/2025 as payment under the non-employee director compensation program in lieu of retainer fees. Each RSU converts to one share at settlement and the grant carried a reported price of $0 (i.e., issued as compensation). After the grant, the filing reports Mr. Fetter directly beneficially owns 10,705 shares and indirectly beneficially owns 111,200 shares through an LLC he solely controls, for a combined beneficial position of 121,905 shares.
The form was signed by an attorney-in-fact on 10/07/2025. The filing discloses that settlement timing follows plan terms and that the indirect holdings are held via the limited liability company of which Mr. Fetter is the sole member.
Insider transaction by Omada Health director Jeryl L. Hilleman: the filing reports that on 10/05/2025 the reporting person was granted 1,126 restricted stock units (RSUs) under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents the right to receive one share of common stock with settlement terms set by the Program. After the grant, the reporting person beneficially owns 11,238 shares of common stock. The RSUs were recorded at a price of $0 because they were compensation awards rather than purchases. The Form 4 was signed by an attorney-in-fact on 10/07/2025.